{
  "trial_id": "NCT00517504",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "36-84 month old children",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Child must meet the DSM-IV criteria for AD or PDD NOS as determined via a parent interview on the ADI-R and on child observation via the ADOS, or DD.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Child must have categorical and dimensional evidence of clinically significant ADHD symptoms in multiple settings that have been present for at least six months",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "concurrent non-pharmacological therapies will be stabilized for a minimum period of 2 weeks prior to the child's entry into the drug phase of the study.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Screening assessment: The child's parent and teacher/daycare provider, if applicable, will need to complete some forms that describe the child's problems with overactivity, impulsivity and inattention.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Medication phase: After screening assessments are completed, the child will enter the medication phase of the study.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "The child and his/her parents will come back each week for a clinic visit. At each visit the child's height, weight, blood pressure and pulse will be checked.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "36-84 month old children",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Child must meet the DSM-IV criteria for AD or PDD NOS as determined via a parent interview on the ADI-R and on child observation via the ADOS, or DD.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Child must have categorical and dimensional evidence of clinically significant ADHD symptoms in multiple settings that have been present for at least six months",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "concurrent non-pharmacological therapies will be stabilized for a minimum period of 2 weeks prior to the child's entry into the drug phase of the study.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Screening assessment: The child's parent and teacher/daycare provider, if applicable, will need to complete some forms that describe the child's problems with overactivity, impulsivity and inattention.",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Child with prior failed treatment with an adequate trial of methylphenidate;",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Current history of chronic tic disorder (e.g., Tourette syndrome with current severity of moderate or more), or a family history of Tourette's Disorder.",
      "label": "unknown",
      "evidence": "quote"
    }
  ],
  "notes": "The patient is a 57-year-old man with abdominal pain and vomiting. He drinks around 60 units of alcohol per week and smokes 22 cigarettes per day.",
  "_meta": {
    "topic_id": "21",
    "trial_id": "NCT00517504",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}